Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05174858
Other study ID # ETIKOL
Secondary ID 2021-A02568-33
Status Completed
Phase N/A
First received
Last updated
Start date January 25, 2022
Est. completion date May 20, 2022

Study information

Verified date May 2022
Source ACTEON Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a multicentric randomised (2 groups, ratio 1:1) Post Market Clinical Follow-up trial. 38 subjects (teeth) requiring a simple tooth extraction or multiple tooth extraction on the same quadrant and taking curative or preventive antithrombotic treatment will be included (19 in each group). The aim of the study is to assess the efficacy of ETIK COLLAGENE (Topical hemostatic collagen-product) on the hemostasis (time to stop bleeding) after tooth extraction. The hemostasis is measured by assessing the presence of bleeding within the first 8 minutes post-extraction. Group 1: intra-alveolar placement of ETIK COLLAGENE immediately after tooth extraction. Group 2: the alveolus is left empty after tooth extraction (the use of ETIK COLLAGENE is delayed 8 minutes after tooth extraction, before suture). Subjects will be followed-up to 7 days.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date May 20, 2022
Est. primary completion date May 20, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or female, age > 18 years old, - Patient undergoing a simple tooth extraction or multiple tooth extraction on the same quadrant, - Patient taking curative or preventive antithrombotic treatment or patient with a moderate thrombocytopenia, - Patient reachable after surgery, - Signed informed consent form, - Subject affiliated to a health insurance system, or is a beneficiary. Exclusion Criteria: - Known allergy to bovine collagen, - Preoperative INR<1.5 or >3 or instable, - Patient with high risk of bleeding, history of postoperative hemorrhagic complication, - Treatment with bone resorption inhibitor, or patient irradiated at the cervico-facial level, - Contraindication to anesthesia using articaine with 1:200,000 epinephrine, - Clinical follow-up expected to be difficult, - Presence of uncontrolled hypertension, uncompensated diabetes or other clinically relevant systemic alterations, - Current participation in another clinical trial or subject still within the exclusion period of a previous clinical trial, - Vulnerable subjects.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Hemostatic dressing ETIK COLLAGENE
The hemostatic dressing ETIK COLLAGENE is placed in the alveolus immediately after tooth extraction. The presence of bleeding in the alveolus is assessed every 30 seconds for 8 minutes; then the surgical site is sutured.
Other:
Comparator
The alveolus is left empty after tooth extraction. The presence of bleeding in the alveolus is assessed every 30 seconds for 8 minutes; then the dressing ETIK COLLAGENE is placed in the alveolus and the surgical site is sutured.

Locations

Country Name City State
France Faculté d'odontologie du CHU Nantes Nantes
France CSD Rennes Rennes

Sponsors (2)

Lead Sponsor Collaborator
ACTEON Group Slb Pharma

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of time to hemostasis after tooth extraction For each patient, the time to stop bleeding (expressed in minutes) is assessed as follows : every 30 seconds from the tooth extraction (T0) to 8 minutes post extraction, the oral surgeon observes the alveolus during 5 seconds and records the presence or absence of bleeding. over 8 minutes after tooth extraction
Secondary Rate of bleeding at 20 minutes % patients with bleeding occurring after suture, during the 10-minutes local compression period. 20 minutes after tooth extraction
Secondary Occurrence of secondary post-extraction bleeding Number of post-extraction bleeding 7 days
Secondary Level of pain after dental extraction by a numeric scale The pain is assessed by patients in a diary using a numeric scale (range from 0 (= no pain) to 10 (= the worst pain)) each day from the end of the oral surgery to Day 3. At the end of the oral surgery, day 1, day 2, day 3
Secondary Number of adverse and serious adverse events Adverse events recorded from the tooth extraction to the end of follow-up visit will be used to assess the safety of hemostatic dressing and surgical procedures. From the end of the oral surgery to Day 7
See also
  Status Clinical Trial Phase
Recruiting NCT05214664 - Efficiency of a Guiding Device for Inferior Alveolar Nerve Block, EZ-Block®, Compared to a Conventional Freehand Administration. N/A
Active, not recruiting NCT04299750 - Impact of a Alveolar Ridge Preservation Technique on the Need of Performing Guided Bone Regeneration for Dental Implant Placement N/A
Completed NCT06165692 - The Use of Platelet-rich-fibrin in Lower Third Molar Surgery. N/A
Recruiting NCT05201664 - Surgical Extrusion: Volumetric and Insertion Analysis at 6 Months.
Completed NCT05963750 - Assessment of the Impact of Virtual Reality on Patient Anxiety During Dental Avulsions Under Local Anesthesia N/A
Active, not recruiting NCT04009161 - Osteoradionecrosis Rate in Patients Undergoing Radiotherapy for Head and Neck Cancer Treatment.
Recruiting NCT06212232 - A New Piezoelectric Technique in Third Molar Surgery N/A
Completed NCT05830747 - Effect of Pre-emptive Dose of Prednisone Versus Placebo in Impacted Third Molar Surgery Phase 4